ArticleGland surgery2019
Clinical study on surgical treatment of granulomatous lobular mastitis.
Article in Gland surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A meta-analysis of idiopathic granulomatous mastitis treatments for remission and recurrence prevention.Frontiers in medicine · 2024Pooled it
- Beyond breast abscess and malignancy: a case of bilateral idiopathic granulomatous mastitis.Annals of medicine and surgery (2012) · 2026Article
- The diagnostic dilemma of idiopathic granulomatous mastitis with an emphasis on histopathologic findings.Diagnostic pathology · 2025Article
- Analysis of three treatment methods for granulomatous lobular mastitis: a retrospective study in a single center.Frontiers in oncology · 2025Article
- A single center experience with a rare clinical entity of idiopathic granulomatous mastitis: Case series and review of the literature.International journal of surgery case reports · 2024Article
- The Predictive Value of Preoperative Systemic Immune-Inflammation Index in Patients with Granulomatous Mastitis.Journal of inflammation research · 2024Article
- Dermis-retained breast dermo-glandular flap: a new surgical approach for granulomatous lobular mastitis.Frontiers in surgery · 2023Article
- Ozone therapy as a novel complementary therapeutic approach in refractory idiopathic granulomatous mastitis.Frontiers in medicine · 2023Article
- Article
- Granulomatous mastitis: A case report.SAGE open medical case reports · 2022Article
- The Effectiveness of Traditional Chinese Medicine Combined With Surgery to Treat Granulomatous Mastitis: A Propensity-Matched Analysis.Frontiers in oncology · 2022Article
- Treatment of bilateral granulomatous lobular mastitis during lactation with traditional Chinese medicine: A case report.World journal of clinical cases · 2021Article
- A clinical observation of stage I implant breast reconstruction for mass-like granulomatous lobular mastitis.Gland surgery · 2021Article
- Management of idiopathic granulomatous mastitis in lactation: case report and review of the literature.International breastfeeding journal · 2021Review
- The expression and meaning of CD68, CD163, CD57, and IgG4 in granulomatous lobular mastitis.Gland surgery · 2020Article
- Comment on: clinical study on surgical treatment of granulomatous lobular mastitis.Gland surgery · 2020Article
Corrections and comments
- Commented on by
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe etiology and pathogenesis of granulomatous lobular mastitis (GLM) remain unknown, with no unified evaluation criteria or standard treatments. This study aimed to assess the etiology and features of GLM, as well as the effects of surgery (lesion excision + stage I breast reconstruction; LE + BR) for GLM.
methodsThis study evaluated 178 female GLM patients retrospectively in 2006-2015. The surgery and non-surgery groups included 164 and 14 patients, respectively. All patients received conservative therapy (traditional Chinese medicine combined with regional wet compress and pus drainage). In addition, the surgery group (n=164) underwent LE + BR. Clinical data, including disease course, causes, lesion size, marital status, and treatment approaches, were assessed.
resultsFollow-up was 13-117 months. Seventy-five of the 178 patients had no overt causes (42.1%); meanwhile, 63 (35.4%) and 16 (9.0%) had congenital nipple retraction and a history of psychotropic drugs for >1 year, respectively. The surgery group showed lesions significantly shrunk (≤1 quadrant) with acute inflammation fully controlled; 8 showed recurrence, indicating a cure rate of 95.1% (156/164). In the non-surgery group, 4 cases showed relapse after 6-14 months (cure rate =71.4%; 10/14). Therefore, surgical treatment was significantly more efficient than non-surgical treatment (P=0.001). Kaplan-Meier survival curves for the two treatment types showed a significant difference in recurrence (log rank =11.84, P<0.001).
conclusionsIn GLM patients, LE + BR is safe and effective with respect to cosmetic results, recovery time, and recurrence. Successful surgery should be performed for patients whose lesions ≤1 quadrant, aim to achieve optimal GLM treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.